“a parachute so golden it should be stored at Ft. Knox” (in the Los Angeles Times)

Link: http://www.latimes.com/business/technology/la-fi-tn-yahoo-board-20160324-snap-htmlstory.html

——————–

I am told this story will be on the front page The Los Angeles Times
business section Friday morning.

http://www.latimes.com/business/technology/la-fi-tn-yahoo-board-20160324-snap-htmlstory.html
_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

on NPR Morning Edition’s MarketPlace: Yahoo faces a proxy battle for control of its board

Link: http://167.88.156.220/podcast/marketplace/morning_report/2016/03/24/mmr_20160324_pod_64.mp3?srcid=edit&listeningSessionID=56e8655bd6320626_762102_pSpu8VbM_0000000GRp6

——————–

On NPR Morning Edition MarketPlace Report, this morning, a story about
corporate control and the looming proxy battle between incumbent management
and hedge fund, Starboard, for control of the Yahoo board:

http://167.88.156.220/podcast/marketplace/morning_report/2016/03/24/mmr_20160324_pod_64.mp3?srcid=edit&listeningSessionID=56e8655bd6320626_762102_pSpu8VbM_0000000GRp6

Or, attached as an mp3
_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

on the firing of Valeant’s CEO and others

Link: http://www.reuters.com/article/us-valeant-ceo-legal-idUSKCN0WN2FL

——————–

and the company’s accusation that they are the wrongdoers in Valeant’s
accounting woes:

Reuters:

http://www.reuters.com/article/us-valeant-ceo-legal-idUSKCN0WN2FL

CNBC:

http://www.cnbc.com/2016/03/21/reuters-america-valeants-harsh-words-on-ex-executives-may-play-into-govt-probes.html

Fortune magazine:

http://fortune.com/2016/03/21/valeant-cfo-improper-conduct/


_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Just when you thought (or hoped) there was nothing more to say about Valeant

Link: http://www.ft.com/intl/cms/s/0/a710912e-eb5b-11e5-bb79-2303682345c8.html#axzz434j3l7v4

——————–

>From The Financial Times (UK):

“If you are a Valeant debt holder the first thing you want to see is new
management. The second thing is to make sure the parts of Valeant that can
be sold quickly for cash are sold,” said Erik Gordon, professor at the
University of Michigan Ross School of Business.

“Bondholders are going to now be looking at the sum of parts, and asking
what can be sold in [the] next 12-18 months and how much recovery they can
get in a worst-case scenario.”

http://www.ft.com/intl/cms/s/0/a710912e-eb5b-11e5-bb79-2303682345c8.html#axzz434j3l7v4

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Entrepreneurial angle on the Valeant crash

Link: http://www.statnews.com/pharmalot/2016/03/15/valeant-drug-prices/

——————–

At STAT (website and news service for the pharma industry and pharma equity
analysts), on Valeant losing half its market value in one morning:

“Its business model wasn’t sustainable,” said Erik Gordon, a business and
law professor at the University of Michigan. “But you have to hope that its
fiery crash doesn’t discourage entrepreneurs from experimenting with other
new models, because it is not clear that the mainstream pharma model is the
best one to address the new realities of healthcare.”

Valeant slashes financial outlook; investors flee ‘a broken company’


_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Valeant’s crash – a new school of management

Link: http://abcnews.go.com/Business/wireStory/valeant-falls-short-4q-slashes-guidance-37652781

——————–

Valeant Pharmaceuticals lost 50% of its market value today, following a
string of management miscues, including a meeting this morning that was
meant to reassure investors but did the opposite and even featured a slide
with the wrong projected earnings number.

>From a story that ran in many places via The Associated Press wire:

“It’s kind of the Inspector Clouseau school of management,” said Erik
Gordon, a professor and pharmaceuticals analyst at University of Michigan’s
Ross School of Business. “This is a fabulous example of getting everything
wrong” when you’re trying to reassure investors.

At abc News:

http://abcnews.go.com/Business/wireStory/valeant-falls-short-4q-slashes-guidance-37652781

In The San Fransisco Chronicle

In the UK’s Daily Mail:

http://www.dailymail.co.uk/wires/ap/article-3493012/Valeant-falls-short-4Q-slashes-guidance.html
_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Drug prices, on NPR’s Morning Edition Marketplace Report this morning

Link: http://167.88.156.220/podcast/marketplace/morning_report/2016/03/15/mmr_20160315_pod_64.mp3?srcid=edit&listeningSessionID=56e8655bd6320626_13894_SfkG8kH3_00000000EP7

——————–

More talk about Valeant and its business model of buying companies and
raising the prices of its drugs. (The second story in this morning’s
story.)

http://167.88.156.220/podcast/marketplace/morning_report/2016/03/15/mmr_20160315_pod_64.mp3?srcid=edit&listeningSessionID=56e8655bd6320626_13894_SfkG8kH3_00000000EP7

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

VW, social responsibility, brand damage

Link: http://washpost.bloomberg.com/Story?docId=1376-O3VA9T6JIJUT01-4CMEVT3V9EMFH4MBMHHAL7FOQ4

——————–

In The Washington Post and Bloomberg Businessweek:

“VW executives have mismanaged the problems in a way that makes the brand
untouchable to the socially responsible Millennial generation in America,”
Erik Gordon, a professor at the University of Michigan’s Ross School of
Business, said in an e-mail.

http://washpost.bloomberg.com/Story?docId=1376-O3VA9T6JIJUT01-4CMEVT3V9EMFH4MBMHHAL7FOQ4

http://www.bloomberg.com/news/articles/2016-03-11/vw-brand-february-sales-drop-as-scandal-weighs-on-u-s-demand

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan